Nuzenio

Ii Endpoint

Ii Endpoint news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 3 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Micot Pharma's MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026 - FinancialContentFinancialContent · Fri, 07 Aug 2026 08:36:00 GMT Bezisterim meets motor and non-motor endpoints in phase II early Parkinson's trial. - AllSciAllSci · Thu, 06 Aug 2026 16:12:09 GMT BioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program - fiercebiotech.comfiercebiotech.com · Thu, 06 Aug 2026 13:40:09 GMT Sonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers - AstraZenecaAstraZeneca · Mon, 27 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 08:36:00 GMTMicot Pharma's MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026 - FinancialContent

Thu, 06 Aug 2026 16:12:09 GMTBezisterim meets motor and non-motor endpoints in phase II early Parkinson's trial. - AllSci

Thu, 06 Aug 2026 13:40:09 GMTBioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program - fiercebiotech.com

Mon, 27 Jul 2026 07:00:00 GMTSonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers - AstraZeneca

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Parkinson4 live mentions Achieves Primary Endpoint2 live mentions Phase II Trial2 live mentions Novel Integrated Multi2 live mentions Neuroprotection Mechanism2 live mentions Be Presented2 live mentions WSC2 live mentions BioVie2 live mentions GEJ2 live mentions Micot Pharma1 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ii Endpoint.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.